(RDVT) Red Violet - NASDAQ
Sector: Technology | Industry: Software - Application | Exchange: NASDAQ (USA) | Market Cap: 786m USD | Total Return: 15.2% in 12m
Avg Turnover: 7.54M
Qual. Beats: 3
Rev. Trend: 99.7%
Qual. Beats: 2
Warnings
No concerns identified
Tailwinds
Supp Ema20, Idiosyncratic Leader
Red Violet, Inc. (RDVT) is a Florida-based data analytics firm providing identity intelligence and investigative solutions. The company operates through two primary platforms: idiCORE, designed for due diligence and fraud detection, and FOREWARN, a mobile application focused on real-time risk mitigation for professionals during consumer engagements.
The business model relies on a cloud-native proprietary technology stack that aggregates large-scale disparate data sets to provide actionable insights. As a player in the Research & Consulting Services sector, Red Violet serves a diverse client base including law enforcement, financial services, and corporate security firms. Investors can utilize ValueRay to further evaluate the companys financial health and growth metrics.
Red Violet generates revenue through subscription-based models and transactional usage, marketing its services via direct sales and a network of strategic partners. The company focuses on the high-demand identity verification market, which is driven by increasing regulatory compliance requirements and the rising prevalence of digital fraud.
- Expansion of FOREWARN user base among real estate and service professionals
- Growth in idiCORE adoption across financial services and government sectors
- Scalability of proprietary cloud-based analytics platform drives operating leverage
- Regulatory changes impacting data privacy and identity intelligence accessibility
- Competitive pressure from legacy data providers affecting market share and pricing
| Net Income: 14.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.25 > 0.02 and ΔFCF/TA 6.97 > 1.0 |
| NWC/Revenue: 55.48% < 20% (prev 51.21%; Δ 4.27% < -1%) |
| CFO/TA 0.27 > 3% & CFO 30.9m > Net Income 14.1m |
| Net Debt (-40.7m) to EBITDA (23.4m): -1.74 < 3 |
| Current Ratio: 11.22 > 1.5 & < 3 |
| Outstanding Shares: last quarter (14.4m) vs 12m ago -0.67% < -2% |
| Gross Margin: 84.23% > 18% (prev 82.55%; Δ 1.68% > 0.5%) |
| Asset Turnover: 88.87% > 50% (prev 80.41%; Δ 8.46% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.46 (Total Current Assets 57.3m - Total Current Liabilities 5.11m) / Total Assets 112.6m |
| B: 0.15 (Retained Earnings 16.7m / Total Assets 112.6m) |
| C: 0.14 (EBIT TTM 15.1m / Avg Total Assets 105.9m) |
| D: 12.90 (Book Value of Equity 104.5m / Total Liabilities 8.11m) |
| Altman-Z'' = 18.02 = AAA |
| DSRI: 1.05 (Receivables 11.9m/9.65m, Revenue 94.1m/79.7m) |
| GMI: 0.98 (GM 82.55% / 84.23%) |
| AQI: 0.90 (AQ_t 0.46 / AQ_t-1 0.51) |
| SGI: 1.18 (Revenue 94.1m / 79.7m) |
| TATA: -0.15 (NI 14.1m - CFO 30.9m) / TA 112.6m) |
| Beneish M = -2.95 (Cap -4..+1) = A |
As of June 16, 2026, the stock is trading at USD 55.54 with a total of 82,640 shares traded.
Over the past week, the price has changed by +3.83%,
over one month by +18.35%,
over three months by +43.40% and
over the past year by +15.23%.
Red Violet has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy RDVT.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 63.5 | 14.3% |
P/E Trailing = 57.4021
P/S = 8.3503
P/B = 7.2483
Revenue TTM = 94.1m USD
EBIT TTM = 15.1m USD
EBITDA TTM = 23.4m USD
Long Term Debt = 2.33m USD (estimated: total debt 2.72m - short term 391k)
Short Term Debt = 391k USD (from shortTermDebt, last quarter)
Debt = 2.72m USD (from shortLongTermDebtTotal, last quarter) (leases 2.72m already included)
Net Debt = -40.7m USD (calculated: Debt 2.72m - CCE 43.5m)
Enterprise Value = 744.9m USD (785.6m + Debt 2.72m - CCE 43.5m)
Interest Coverage Ratio = unknown (Ebit TTM 15.1m / Interest Expense TTM 0.0)
EV/FCF = 26.93x (Enterprise Value 744.9m / FCF TTM 27.7m)
FCF Yield = 3.71% (FCF TTM 27.7m / Enterprise Value 744.9m)
FCF Margin = 29.40% (FCF TTM 27.7m / Revenue TTM 94.1m)
Net Margin = 14.99% (Net Income TTM 14.1m / Revenue TTM 94.1m)
Gross Margin = 84.23% ((Revenue TTM 94.1m - Cost of Revenue TTM 14.8m) / Revenue TTM)
Gross Margin QoQ = 85.21% (prev 94.68%)
Tobins Q-Ratio = 6.61 (Enterprise Value 744.9m / Total Assets 112.6m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 2.72m)
Taxrate = 10.90% (1.73m / 15.8m)
NOPAT = 13.5m (EBIT 15.1m * (1 - 10.90%))
Current Ratio = 11.22 (Total Current Assets 57.3m / Total Current Liabilities 5.11m)
Debt / Equity = 0.03 (Debt 2.72m / totalStockholderEquity, last quarter 104.5m)
Debt / EBITDA = -1.74 (Net Debt -40.7m / EBITDA 23.4m)
Debt / FCF = -1.47 (Net Debt -40.7m / FCF TTM 27.7m)
Total Stockholder Equity = 100.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 13.32% (Net Income 14.1m / Total Assets 112.6m)
RoE = 13.98% (Net Income TTM 14.1m / Total Stockholder Equity 100.8m)
RoCE = 14.63% (EBIT 15.1m / Capital Employed (Equity 100.8m + L.T.Debt 2.33m))
RoIC = 13.03% (NOPAT 13.5m / Invested Capital 103.2m)
WACC = 10.95% (E(785.6m)/V(788.3m) * Re(10.99%) + D(2.72m)/V(788.3m) * Rd(0.0%) * (1-Tc(0.11)))
Discount Rate = 10.99% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 55.56 | Cagr: 1.29%
[DCF] Terminal Value 70.03% ; FCFF base≈23.6m ; Y1≈27.0m ; Y5≈39.8m
[DCF] Fair Price = 31.91 (EV 409.5m - Net Debt -40.7m = Equity 450.3m / Shares 14.1m; r=10.95% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 2.75 | # QB: 3
Revenue Correlation: 99.66 | Revenue CAGR: 21.30% | SUE: 2.10 | # QB: 2
EPS current Quarter (2026-06-30): EPS=0.34 | Chg30d=+3.08% | Revisions=+20% | Analysts=2
EPS next Quarter (2026-09-30): EPS=0.39 | Chg30d=-3.75% | Revisions=-33% | Analysts=2
EPS current Year (2026-12-31): EPS=1.49 | Chg30d=+10.41% | Revisions=+33% | GrowthEPS=+14.2% | GrowthRev=+16.2%
EPS next Year (2027-12-31): EPS=1.62 | Chg30d=+4.84% | Revisions=+33% | GrowthEPS=+9.4% | GrowthRev=+13.6%
[Analyst] Revisions Ratio: -33%